Key players in the global optometry market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global optometry market. A few expansion strategies adopted by players operating in the global optometry market are:
The report on the global optometry market discussed individual strategies, followed by company profiles of manufacturers of optometry. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global optometry market.
The global optometry market was worth US$ 60.7 Bn and is projected to reach a value of US$ 88.1 Bn by the end of 2027
Optometry market is anticipated to grow at a CAGR of 4.3% during the forecast period
North America accounted for a major share of the global optometry market
Optometry market is driven by key players are investing in the research and development activities to develop and introduce new products thereby boosting the global market
Key players in the global optometry market include CooperVision, Johnson & Johnson Vision Care, Inc., Carl Zeiss, Novartis AG, Essilor, Valeant Pharmaceuticals International, Inc. (Bausch+Lomb Incorporated), ALLERGAN, Pfizer, Inc., F. Hoffmann-La Roche Ltd., Transitions Optical Limited, HOYA GROUP, CIRON Drugs & Pharmaceuticals Pvt. Ltd., NIDEK CO., LTD., TOPCON CORPORATION and GrandVision
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Optometry Market
4. Market Overview
4.1. Introduction
4.1.1. Product type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Optometry Market Analysis and Forecasts, 2017–2027
5. Key Insights
5.1. Regulatory Scenario by Region/globally
5.2. Key Industry Events
5.3. Technological Advancement
6. Global Optometry Market Analysis and Forecasts, by Product type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Optometry Market Value Forecast by Product type, 2017–2027
6.3.1. Therapeutics
6.3.1.1. Anti- inflammatory drugs
6.3.1.2. Anti-fungal drugs
6.3.1.3. Anti- infective drugs
6.3.1.4. Anti-allergy drugs
6.3.2. Vision care equipment
6.3.2.1. Eye glasses
6.3.2.2. Contact lenses
6.4. Global Optometry Market Attractiveness by Product type
7. Global Optometry Market Analysis and Forecasts, by Distribution channel
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Optometry Market Value Forecast by Distribution channel, 2017–2027
7.3.1. Hospital Pharmacies
7.3.2. Online & Retail Stores
7.3.3. Optometry Clinics
7.3.4. Optical Centres
7.3.5. Others
7.4. Global Optometry Market Attractiveness by Distribution channel
8. Global Optometry Market Analysis and Forecasts, by Region
8.1. Key Findings
8.2. Global Optometry Market Value Forecast by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Global Optometry Market Attractiveness by Country/Region
9. North America Optometry Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. North America Optometry Market Value Forecast by Product type, 2017–2027
9.2.1. Therapeutics
9.2.1.1. Anti- inflammatory drugs
9.2.1.2. Anti-fungal drugs
9.2.1.3. Anti- infective drugs
9.2.1.4. Anti-allergy drugs
9.2.2. Vision care equipment
9.2.2.1. Eye glasses
9.2.2.2. Contact lenses
9.3. North America Optometry Market Value Forecast by Distribution channel, 2017–2027
9.3.1. Hospital Pharmacies
9.3.2. Online & Retail Stores
9.3.3. Optometry Clinics
9.3.4. Optical Centres
9.3.5. Others
9.4. North America Optometry Market Value Forecast by Country, 2017–2027
9.4.1. U.S.
9.4.2. Canada
9.5. North America Optometry Market Attractiveness Analysis
9.5.1. By Product type
9.5.2. By Distribution channel
9.5.3. By Country
10. Europe Optometry Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Europe Optometry Market Value Forecast by Product type, 2017–2027
10.2.1. Therapeutics
10.2.1.1. Anti- inflammatory drugs
10.2.1.2. Anti-fungal drugs
10.2.1.3. Anti- infective drugs
10.2.1.4. Anti-allergy drugs
10.2.2. Vision care equipment
10.2.2.1. Eye glasses
10.2.2.2. Contact lenses
10.3. Europe Optometry Market Value Forecast by Distribution channel, 2017–2027
10.3.1. Hospital Pharmacies
10.3.2. Online & Retail Stores
10.3.3. Optometry Clinics
10.3.4. Optical Centres
10.3.5. Others
10.4. Europe Optometry Market Value Forecast by Country/Sub-region, 2017–2027
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Europe Optometry Market Attractiveness Analysis
10.5.1. By Product type
10.5.2. By Distribution channel
10.5.3. By Country/Sub-region
11. Asia Pacific Optometry Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Asia Pacific Optometry Market Value Forecast by Product type, 2017–2027
11.2.1. Therapeutics
11.2.1.1. Anti- inflammatory drugs
11.2.1.2. Anti-fungal drugs
11.2.1.3. Anti- infective drugs
11.2.1.4. Anti-allergy drugs
11.2.2. Vision care equipment
11.2.2.1. Eye glasses
11.2.2.2. Contact lenses
11.3. Asia Pacific Optometry Market Value Forecast by Distribution channel, 2017–2027
11.3.1. Hospital Pharmacies
11.3.2. Online & Retail Stores
11.3.3. Optometry Clinics
11.3.4. Optical Centers
11.3.5. Others
11.4. Asia Pacific Optometry Market Value Forecast by Country/Sub-region, 2017–2027
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Asia Pacific Optometry Market Attractiveness Analysis
11.5.1. By Product type
11.5.2. By Distribution channel
11.5.3. By Country/Sub-region
12. Latin America Optometry Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Latin America Optometry Market Value Forecast by Product type, 2017–2027
12.2.1. Therapeutics
12.2.1.1. Anti- inflammatory drugs
12.2.1.2. Anti-fungal drugs
12.2.1.3. Anti- infective drugs
12.2.1.4. Anti-allergy drugs
12.3. Latin America Optometry Vision care equipment
12.3.1.1. Eye glasses
12.3.1.2. Contact lenses
12.4. Latin America Optometry Market Value Forecast by Distribution channel, 2017–2027
12.4.1. Hospital Pharmacies
12.4.2. Online & Retail Stores
12.4.3. Optometry Clinics
12.4.4. Optical Centres
12.4.5. Others
12.5. Latin America Optometry Market Value Forecast by Country/Sub-region, 2017–2027
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Rest of Latin America
12.6. Latin America Optometry Market Attractiveness Analysis
12.6.1. By Product type
12.6.2. By Distribution channel
12.6.3. By Country/Sub-region
13. Middle East & Africa Optometry Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Middle East & Africa Optometry Market Value Forecast by Product type, 2017–2027
13.2.1. Therapeutics
13.2.1.1. Anti- inflammatory drugs
13.2.1.2. Anti-fungal drugs
13.2.1.3. Anti- infective drugs
13.2.1.4. Anti-allergy drugs
13.2.2. Vision care equipment
13.2.2.1. Eye glasses
13.2.2.2. Contact lenses
13.3. Middle East & Africa Optometry Market Value Forecast by Distribution channel, 2017–2027
13.3.1. Hospital Pharmacies
13.3.2. Online & Retail Stores
13.3.3. Optometry Clinics
13.3.4. Optical Centres
13.3.5. Others
13.4. Middle East & Africa Optometry Market Value Forecast by Country/Sub-region, 2017–2027
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Middle East & Africa Optometry Market Attractiveness Analysis
13.5.1. By Product type
13.5.2. By Distribution channel
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (By Tier and Size of companies)
14.2. Market Share Analysis/Ranking By Company (2018)
14.3. Company Profiles
14.3.1. CooperVision
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Growth Strategies
14.3.1.3. SWOT Analysis
14.3.2. Johnson & Johnson Vision Care, Inc.
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Growth Strategies
14.3.2.3. SWOT Analysis
14.3.3. Carl Zeiss
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Growth Strategies
14.3.3.3. SWOT Analysis
14.3.4. Novartis AG
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Growth Strategies
14.3.4.3. SWOT Analysis
14.3.5. Essilor
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Growth Strategies
14.3.5.3. SWOT Analysis
14.3.6. Valeant Pharmaceuticals International, Inc. (Bausch+Lomb Incorporated)
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Growth Strategies
14.3.6.3. SWOT Analysis
14.3.7. ALLERGAN
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Growth Strategies
14.3.7.3. SWOT Analysis
14.3.8. Pfizer, Inc.
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Growth Strategies
14.3.8.3. SWOT Analysis
14.3.9. F. Hoffmann-La Roche Ltd.
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Growth Strategies
14.3.9.3. SWOT Analysis
14.3.10. Transitions Optical Limited
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Growth Strategies
14.3.10.3. SWOT Analysis
14.3.11. HOYA GROUP
14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.11.2. Growth Strategies
14.3.11.3. SWOT Analysis
14.3.12. CIRON Drugs & Pharmaceuticals Pvt. Ltd.
14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.12.2. Growth Strategies
14.3.12.3. SWOT Analysis
14.3.13. NIDEK CO., LTD.
14.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.13.2. Growth Strategies
14.3.13.3. SWOT Analysis
14.3.14. TOPCON CORPORATION
14.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.14.2. Growth Strategies
14.3.14.3. SWOT Analysis
14.3.15. GrandVision
14.3.15.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.15.2. Growth Strategies
14.3.15.3. SWOT Analysis
List of Table
Table 01: Global estimate of the number of people visually impaired by age (2018)
Table 02: Global Optometry Market Size (US$ Mn) Forecast, by Product, 2017-2027
Table 03: Global Optometry Market Size (US$ Mn) Forecast, by Therapeutics, 2017-2027
Table 04: Global Optometry Market Size (US$ Mn) Forecast, by Anti-inflammatory Drugs, 2017-2027
Table 05: Global Optometry Market Size (US$ Mn) Forecast, by Vision Care Equipment, 2017-2027
Table 06: Global Optometry Market Size (US$ Mn) Forecast, by Contact Lenses, 2017-2027
Table 07: Global Optometry Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2027
Table 08: Global Optometry Market Size (US$ Mn) Forecast, by Region, 2017-2027
Table 09: North America Optometry Market Size (US$ Mn) Forecast, by Country, 2017-2027
Table 10: North America Optometry Market Size (US$ Mn) Forecast, by Product Type, 2017-2027
Table 11: North America Optometry Market Size (US$ Mn) Forecast, by Product Type – Therapeutics, 2017-2027
Table 12: North America Optometry Market Size (US$ Mn) Forecast, by Therapeutics – Anti-inflammatory Drugs, 2017-2027
Table 13: North America Optometry Market Size (US$ Mn) Forecast, by Product Type – Vision Care Equipment, 2017-2027
Table 14: North America Optometry Market Size (US$ Mn) Forecast, by Vision Care Equipment – Contact Lenses, 2017-2027
Table 15: North America Optometry Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2027
Table 16: Europe Optometry Market Size (US$ Mn) Forecast, by Country, 2017-2027
Table 17: Europe Optometry Market Size (US$ Mn) Forecast, by Product Type, 2017-2027
Table 18: Europe Optometry Market Size (US$ Mn) Forecast, by Product Type – Therapeutics, 2017-2027
Table 19: Europe Optometry Market Size (US$ Mn) Forecast, by Therapeutics – Anti-inflammatory Drugs, 2017-2027
Table 20: Europe Optometry Market Size (US$ Mn) Forecast, by Product Type – Vision Care Equipment, 2017-2027
Table 21: Europe Optometry Market Size (US$ Mn) Forecast, by Vision Care Equipment – Contact Lenses, 2017-2027
Table 22: Europe Optometry Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2027
Table 23: Asia Pacific Optometry Market Size (US$ Mn) Forecast, by Country, 2017-2027
Table 24: Asia Pacific Optometry Market Size (US$ Mn) Forecast, by Product, 2017-2027
Table 25: Asia Pacific Optometry Market Size (US$ Mn) Forecast, by Therapeutics, 2017-2027
Table 26: Asia Pacific Optometry Market Size (US$ Mn) Forecast, by Anti-inflammatory Drugs, 2017-2027
Table 27: Asia Pacific Optometry Market Size (US$ Mn) Forecast, by Vision Care Equipment, 2017-2027
Table 28: Asia Pacific Optometry Market Size (US$ Mn) Forecast, by Contact Lenses, 2017-2027
Table 29: Asia Pacific Optometry Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2027
Table 30: Latin America Optometry Market Size (US$ Mn) Forecast, by Country, 2017-2027
Table 31: Latin America Optometry Market Size (US$ Mn) Forecast, by Product Type, 2017-2027
Table 32: Latin America Optometry Market Size (US$ Mn) Forecast, by Product Type – Therapeutics, 2017-2027
Table 33: Latin America Optometry Market Size (US$ Mn) Forecast, by Therapeutics – Anti-inflammatory Drugs, 2017-2027
Table 34: Latin America Optometry Market Size (US$ Mn) Forecast, by Product Type – Vision Care Equipment, 2017-2027
Table 35: Latin America Optometry Market Size (US$ Mn) Forecast, by Vision Care Equipment – Contact Lenses, 2017-2027
List of Figure
Figure 01: Global Optometry market, by Product Type, Market Size (US$ Mn), 2018 (A)
Figure 02: Optometry market revenue (%), by top three segments, 2018 (A)
Figure 03: Executive Summary (2/3)
Figure 04: Executive Summary (3/3)
Figure 05: Opportunity Map, 2018
Figure 06: Opportunity Map, 2018
Figure 07: Key Industry Developments
Figure 09: Percentage of eye major eye diseases in the world
Figure 08: Global Optometry Market Size (US$ Mn) Forecast, 2019-2027
Figure 10: Global Optometry Market Value Share, by Product, 2018 and 2027
Figure 11: Global Optometry Market Attractiveness, by Product, 2019–2027
Figure 12: Global Optometry Market Value Share, by Therapeutics, 2018 and 2027
Figure 13: Global Optometry Market Attractiveness, by Therapeutics, 2019–2027
Figure 14: Global Optometry Market Value Share, by Vision Care Equipment, 2018 and 2027
Figure 15: Global Optometry Market Attractiveness, by Vision Care Equipment,2019–2027
Figure 16: Global Optometry Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Anti-inflammatory Drugs, 2017-2027
Figure 17: Global Optometry Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Anti-fungal Drugs, 2017-2027
Figure 18: Global Optometry Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Anti-infective Drugs, 2017-2027
Figure 19: Global Optometry Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Anti-allergy Drugs, 2017-2027
Figure 20: Global Optometry Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2017-2027
Figure 21: Global Optometry Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Eye Glasses, 2017-2027
Figure 22: Global Optometry Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Contact Lenses, 2017-2027
Figure 23: Global Optometry Market Value Share, by Distribution Channel, 2018 and 2027
Figure 24: Global Optometry Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospital Pharmacies, 2017-2027
Figure 25: Global Optometry Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Online & Retail Stores, 2017-2027
Figure 26: Global Optometry Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Optometry Clinics, 2017-2027
Figure 27: Global Optometry Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Optical Centers, 2017-2027
Figure 28: Global Optometry Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2017-2027
Figure 29: Global Optometry Market Attractiveness, by Distribution Channel, 2019–2027
Figure 30: Global Market Scenario
Figure 31: Global Optometry Market Value Share, by Region, 2018 and 2027
Figure 32: Global Optometry Market Attractiveness, by Region, 2019–2027
Figure 33: North America Optometry Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2027
Figure 34: North America Optometry Market Attractiveness Analysis, by Country, 2019–2025
Figure 35: North America Optometry Market Value Share Analysis, by Country, 2018 and 2027
Figure 36: North America Optometry Market Value Share, by Product Type, 2018 and 2027
Figure 37: North America Optometry Market Attractiveness Analysis, by Product Type, 2019–2027
Figure 38: North America Optometry Market Value Share, by Therapeutics, 2018 and 2027
Figure 39: North America Optometry Market Value Share, by Vision Care Equipment, 2018 and 2027
Figure 40: North America Optometry Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 41: Europe Optometry Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2027
Figure 42: Europe Optometry Market Attractiveness Analysis, by Country, 2019–2027
Figure 43: Europe Optometry Market Value Share Analysis, by Country, 2018 and 2027
Figure 44: Europe Optometry Market Value Share, by Product Type, 2018 and 2027
Figure 45: Europe Optometry Market Attractiveness Analysis, by Product Type, 2019–2027
Figure 46: Europe Optometry Market Value Share, by Therapeutics, 2018 and 2027
Figure 47: Europe Optometry Market Value Share, by Vision Care Equipment, 2017–2027
Figure 48: Europe Optometry Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 49: Asia Pacific Optometry Market Size (US$ Mn) Forecast, and Y-o-Y Growth (%) Projection, 2017-2027
Figure 50: Asia Pacific Optometry Market Attractiveness, by Country
Figure 51: Asia Pacific Optometry Market Value Share Analysis, by Country, 2018 and 2027
Figure 52: Asia Pacific Optometry Market Value Share, by Product, 2018 and 2027
Figure 53: Asia Pacific Optometry Market Attractiveness, by Product
Figure 54: Asia Pacific Optometry Market Value Share, by Therapeutics, 2018 and 2027
Figure 55: Asia Pacific Optometry Market Value Share, by Vision Care Equipment, 2018-2027
Figure 56: Asia Pacific Optometry Market Value Share, by Distribution Channel, 2018 and 2027
Figure 57: Latin America Optometry Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2027
Figure 58: Latin America Optometry Market Attractiveness Analysis, by Country, 2019-2027
Figure 59: Latin America Market Value Share Analysis, by Country, 2018 and 2027
Figure 60: Latin America Optometry Market Value Share Analysis, by Product Type, 2018 and 2027
Figure 61: Latin America Optometry Market Attractiveness Analysis, by Product Type, 2019 -2027
Figure 62: Latin America Optometry Market Value Share, by Product Type – Therapeutics, 2018 and 2027
Figure 63: Latin America Optometry Market Value Share, by Product Type – Vision Care Equipment, 2018 and 2027
Figure 64: Latin America Optometry Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 65: Middle East & Africa Optometry Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 66: Middle East & Africa Optometry Market Attractiveness, by Country, 2019–2027
Figure 67: Middle East & Africa Optometry Market Value Share Analysis, by Country, 2018 and 2027
Figure 68: Middle East & Africa Optometry Market Value Share, by Product, 2018 and 2027
Figure 69: Middle East & Africa Optometry Market Attractiveness, by Product
Figure 70: Middle East & Africa Optometry Market Value Share, by Therapeutics, 2018 and 2027
Figure 71: Middle East & Africa Optometry Market Value Share, by Vision Care Equipment, 2018-2027
Figure 72: Middle East & Africa Optometry Market Value Share, by Distribution Channel, 2018 and 2027
Figure 73: Global Optometry Market Share, by Therapeutics Segment, by Company, 2018
Figure 74: Global Optometry Market Share, by Vision Care Equipment Segment, by Company, 2018
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Optometry Market
